CTS OpTmizer One SFM offers enhanced T cell expansion and high viability while maintaining early memory cell phenotype

CTS OpTmizer One SFM supported more consistent enhanced T cell expansion, while maintaining high cell viability, early memory cell phenotype, and CD4:CD8 ratios with healthy and diseased AML and CLL donor cells

Thank You For Your Interest

    If you engage with the content, EnterpriseGuide will share your data with Thermofisher. For details on their information practices and how to unsubscribe, see their Privacy Policy. You can unsubscribe at any time.

    You have been directed to this site by DemandBytes. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.